Skip to main content

Select Drug Profiles

Original Research
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm
Jordan S. Orange, MD, PhD, Matt Johnson, BA, Barbara Lennert, RN, BSN, MAOM, Katarzyna Shields, PharmD, MBA, BCOP, BCPS, Michael Eaddy, PharmD, PhD
Jordan S. Orange, MD, PhD; Matt Johnson, BA; Barb Lennert, RN, BSN, MAOM; Katarzyna Shields, PharmD, MBA, BCOP, BCPS; Michael Eaddy, PharmD, PhD
Stakeholder Perspective
A Useful Tool for Evaluating Disease Severity and Alternative Treatments Efficacy
Gary Branning, MBA
by Gary Branning, MBA
Read More
Original Research
Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy
Dominic Pilon, MA, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Marie-Noëlle Robitaille, MA, Patrick Lefebvre, MA, Nancy A. Dawson, MD
Dominic Pilon, MA; Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Marie-Noëlle Robitaille, MA; Patrick Lefebvre, MA; Nancy A. Dawson, MD
Stakeholder Perspective
Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer
Brian Caveney, MD, JD, MPH
by Brian Caveney, MD, JD, MPH
Read More
Perspectives
Guru Insights
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Original Research
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
Todd Williamson, PhD, MSc, Rajesh Kamalakar, MS, Augustina Ogbonnaya, MPH, Erin A. Zagadailov, PharmD, MS, Michael Eaddy, PharmD, PhD, Charlie Kreilick, MBA
Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD, MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA
Stakeholder Perspective
The Challenge of Rosacea Treatment
Atheer A. Kaddis, PharmD
by Atheer A. Kaddis, PharmD
Read More
A Look at SIRT Y-90 and the SARAH Trial
Valérie Vilgrain, MD
Read More
Breast Cancer, FDA Approvals, Oncology
Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
Read More
Lung Cancer, Oncology
Smoking Cessation and Lung Cancer
Edward Garon, MD
Read More
Lung Cancer, Oncology
Screening for Lung Cancer
Edward Garon, MD
Read More
Lung Cancer, Oncology
Who Should be Screened for Lung Cancer?
Edward Garon, MD
Read More
Lung Cancer, Oncology
Common Presenting Factors for NSCLC
Edward Garon, MD
Read More
Page 91 of 244
Results 901 - 910 of 2434